MİCHELSEN, B. Et Al. 2019. FRI0403 HIGH BASELINE PATIENT’S COMPARED WITH EVALUATOR’S GLOBAL ASSESSMENT IS ASSOCIATED WITH LOWER RETENTION AND REMISSION RATES OF FIRST TNF INHIBITOR IN AXSPA PATIENTS – DATA FROM THE EUROSPA COLLABORATION. EULAR 2019 , (Madrid, Spain), 887-888.

MİCHELSEN, B., OMBJERG, L., LOFT, A. G., JOSEPH, S., CLUREA, A., MANN, H., ... EKLUND, K.(2019). FRI0403 HIGH BASELINE PATIENT’S COMPARED WITH EVALUATOR’S GLOBAL ASSESSMENT IS ASSOCIATED WITH LOWER RETENTION AND REMISSION RATES OF FIRST TNF INHIBITOR IN AXSPA PATIENTS – DATA FROM THE EUROSPA COLLABORATION . EULAR 2019 (pp.887-888). Madrid, Spain

MİCHELSEN, BRİGİTTE Et Al. "FRI0403 HIGH BASELINE PATIENT’S COMPARED WITH EVALUATOR’S GLOBAL ASSESSMENT IS ASSOCIATED WITH LOWER RETENTION AND REMISSION RATES OF FIRST TNF INHIBITOR IN AXSPA PATIENTS – DATA FROM THE EUROSPA COLLABORATION," EULAR 2019, Madrid, Spain, 2019

MİCHELSEN, BRİGİTTE Et Al. "FRI0403 HIGH BASELINE PATIENT’S COMPARED WITH EVALUATOR’S GLOBAL ASSESSMENT IS ASSOCIATED WITH LOWER RETENTION AND REMISSION RATES OF FIRST TNF INHIBITOR IN AXSPA PATIENTS – DATA FROM THE EUROSPA COLLABORATION." EULAR 2019 , Madrid, Spain, pp.887-888, 2019

MİCHELSEN, B. Et Al. (2019) . "FRI0403 HIGH BASELINE PATIENT’S COMPARED WITH EVALUATOR’S GLOBAL ASSESSMENT IS ASSOCIATED WITH LOWER RETENTION AND REMISSION RATES OF FIRST TNF INHIBITOR IN AXSPA PATIENTS – DATA FROM THE EUROSPA COLLABORATION." EULAR 2019 , Madrid, Spain, pp.887-888.

@conferencepaper{conferencepaper, author={BRİGİTTE MİCHELSEN Et Al. }, title={FRI0403 HIGH BASELINE PATIENT’S COMPARED WITH EVALUATOR’S GLOBAL ASSESSMENT IS ASSOCIATED WITH LOWER RETENTION AND REMISSION RATES OF FIRST TNF INHIBITOR IN AXSPA PATIENTS – DATA FROM THE EUROSPA COLLABORATION}, congress name={EULAR 2019}, city={Madrid}, country={Spain}, year={2019}, pages={887-888} }